clinical trial · NCT07032688
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd.·phase1·recruiting·n = 55
Type 2 DiabetesSHR-3167 InjectionInsulin Degludec Injection
brief summary
The objective of this study is to evaluate the pharmacokinetics and pharmacodynamics of SHR-3167 at steady state in subjects with type 2 diabetes.
started
Aug 11, 2025
primary completion
Mar 1, 2027
completion
Apr 1, 2027
last updated
Apr 17, 2026
official title
A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 Injection at Steady State in Subjects With Type 2 Diabetes
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol